SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Godavari Drugs Board to consider Audited Annual Financial results

18 May 2013 Evaluate

Godavari Drugs has informed that a meeting of the Board of Directors of the Company will be held on May 30, 2013, to consider and approve the Audited Annual Financial results of the Company for the year ended March 31, 2013, and consider recommendation of dividend, if any along with the results of the quarter ended on March 31, 2013.

The above information is a part of company’s filings submitted to BSE.

Godavari Drugs Share Price

130.15 4.05 (3.21%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×